A list of all TROG trials (open, closed, approved for activation, approved
for further development) follows:
| Trial No. |
Trial Title |
| TROG
99.03 |
A Randomised Multicentre Trial Of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in combination with Rituximab (MabThera®) For Stage I – II Low Grade Follicular Lymphoma. |
| TROG
99.04 |
A prospective, non-randomised
study of chemotherapy and radiotherapy for Osteolymphoma (OL). |
| TROG
99.05 |
Tumour volume as an independent
prognostic factor in patients with non-small cell lung cancer: A protocol
for a prospective database. |
| TROG
02.01 |
Randomised clinical trial
of surgery versus surgery plus adjuvant radiotherapy for regional
control in patients with completely resected macroscopic nodal metastatic
melanoma. |
| TROG
02.03 |
Multicentre phase III study
comparing radical synchronous chemo-radiation vs radical radiation
alone in the definitive management of muscle invasive TCC of the urinary
bladder following maximal TUR. |
| TROG
03.01 |
A randomised phase III study
in advanced oesophageal carcinoma to compare dysphagia in patients
treated with radiotherapy versus chemo-radiotherapy. |
| TROG
03.03 |
An ALLG/TROG Prospective
Multicentre Study of Involved-Field Radiotherapy with Transplantation
for Patients with Hodgkin's disease and non-Hodgkin's lymphoma. |
| TROG
03.04 |
Randomised trial investigating
the effect on survival and PSA control of different durations of adjuvant
androgen deprivation in association with definitive radiation treatment
for localised carcinoma of the prostate (RADAR). |
| TROG
03.06 |
A collaborative randomised
phase III trial: The timing of intervention with androgen deprivation
in prostate cancer patients with a rising PSA. |
| TROG
03.07 |
A Randomised Phase II Study
of Two Regimens of Palliative Chemoradiation Therapy in the Management
of Locally Advanced Non Small Cell Lung Cancer. |
| TROG
03.08 |
A randomised trial of re-irradiation
dose for bony metastases (NCIC SC.20). |
| TROG
04.01 |
A paired randomised comparison
of Cavilon Durable Barrier Cream to 10% Glycerine ("Sorbolene) in
the prophylactic management of post-mastectomy irradiation skin care. |
| TROG 04.02 |
Prospective study to determine
the relationships between survival and FIGO stage, tumour volume and
corpus invasion in cervical cancer. |
| TROG 05.01 |
Post-operative concurrent
chemo-radiotherapy versus post-operative radiotherapy in high-risk
cutaneous squamous cell carcinoma of the head and neck. |
| TROG 05.02 |
A prospective single arm
trial of involved field radiotherapy alone for stage I-II low grade
non-gastric marginal zone lymphoma. |
| TROG 06.01 |
Primary chemotherapy with Temozolomide vs radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III study. (EORTC 22033-26033) |
| Trial No. |
Trial Title |
| TROG
03.05 |
A phase III study of regional
RT in early breast cancer (NCIC MA20). |
| TROG
03.02 |
A feasibility study to evaluate
adjuvant chemo-radiotherapy for gastric cancer. |
| TROG 02.02 |
A phase III randomised trial
of concomitant radiation, cisplatin, and tirapazamine vs concomitant
radiation and cisplatin in patients with advanced head and neck cancer. |
| TROG 01.05 |
A pilot randomised controlled
trial of dexamethasone 96mg versus 16mg per day for malignant spinal
cord compression treated by radiotherapy – TROG Superdex Pilot. |
| TROG
01.04 |
A randomised trial of preoperative
radiotherapy for stage T3 adenocarcinoma of rectum. |
| TROG 01.03 |
Concomitant and adjuvant
temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme
(EORTC 26981/22981). |
| TROG
01.02 |
A phase II study of idarubicin
based combined modality therapy in primary central nervous system
lymphoma. |
| TROG 01.01 |
A phase III double-blind,
randomised, placebo-controlled study of erythropoietin when used as
an adjuvant to radiation therapy in patients with head and neck squamous
cell carcinoma (EORTC 22996). |
| TROG 99.06 |
Phase I/II study of trans-urethral
resection followed by modified synchronous chemo-radiation in the
definitive management of localised invasive TCC of the urinary bladder. |
| TROG 99.02 |
A prospective single arm
non randomised study of concurrent radiation and chemotherapy for
the organ conserving treatment of early anal canal cancer. |
| TROG 99.01 |
An ANZLG / TROG Prospective
study of limited chemotherapy and involved field radiotherapy for
patients with clinical stage I – II Hodgkins Disease. |
| TROG 98.06 |
Concurrent radiotherapy and
chemotherapy for oesophageal cancer patients. |
| TROG 98.05 |
A randomised trial of whole
brain irradiation following local treatment of solitary brain metastases. |
| TROG 98.04 |
A phase II study examining
the efficacy of short fractionation radiotherapy for the palliation
of liver metastases. |
| TROG 98.03 |
A randomised trial to compare
rates of disease-free survival in margin-positive patients after radical
prostatectomy for carcinoma of the prostate with or without adjuvant
post-operative radiotherapy. |
| TROG 98.02 |
A randomised phase II study
of two different strategies for chemoradiotherapy of advanced squamous
cell carcinoma of the head and neck. |
| TROG 98.01 |
A Phase II trial of preoperative
radiotherapy with protracted infusion 5-fluorouracil for resectable
adenocarcinoma of rectum. |
| TROG 97.01 |
A Phase II study of trans-urethral
resection followed by synchronous chemo-radiation in the definitive
treatment of localised TCC of the urinary bladder. |
| TROG 96.07 |
A Phase II study of synchronous
carboplatin/etopside and radiation in Merkel cell carcinoma of the
skin. |
| TROG 96.06 |
A Phase II study of radiation
therapy following nodal surgery in malignant melanoma. |
| TROG 96.05 |
A prospective randomised
trial of single fraction versus fractionated radiotherapy for neuropathic
pain due to bone metastases. |
TROG 96.04 |
Phase III comparison of radiotherapy with glucocorticoid steroid support for the palliation of liver metastases |
TROG 96.03 |
Concomitant accelerated radiotherapy boost for good prognosis oesophageal patients |
| TROG 96.02 |
Standard radio-chemotherapy
for oesophageal cancer patients. |
| TROG 96.01 |
A randomised trial investigating
the effectiveness of different durations of maximal androgen deprivation
prior to and during definitive radiation therapy for locally advanced
carcinoma of the prostate. |
| TROG 95.03 |
Phase III double blind study
of pentosan polysulphate sodium (PPS) in the treatment of late (chronic)
radiation proctitis. |
| TROG 95.02 |
A phase III double-blind
randomised trial of rectal sucralfate suspension in the treatment
of radiation proctitis. |
TROG 95.01 |
A randomised trial comparing adjuvant protracted venous infusion and bolus 5FU/Leucovorin with either early or late radiotherapy in rectal Cancer |
| TROG 94.01 |
A randomised phase III trial
comparing surgery alone with concurrent preoperative radiation and
chemotherapy followed by surgery for localised resectable carcinoma
of the oesophagus. |
| TROG 92.01 |
A phase II study of intravenous
methotrexate and cranial irradiation in the treatment of primary central
nervous system lymphoma (PCNSL). |
| TROG 91.01 |
Phase III accelerated head
and neck trial. |
| TROG 89.04 |
Synchronous radiotherapy
and chemotherapy in oesophageal cancer. |
| TROG 89.03 |
Phase II study of accelerated
fractionation radiotherapy for stage III squamous carcinoma of the
upper aero-digestive tract. |
| TROG 89.02 |
Simultaneous adjuvant radiation
and CMF chemotherapy following surgery for breast cancer. |
